Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Accessibility of Somatic Genetic Testing for Cancer Treatment Decisions.

Annual review of medicine - 1 Jan 2026

Klavans Madison, Musa Fernanda B, Huang Marilyn

Abstract excerpt

Advances in cancer genomics have significantly influenced and improved oncologic treatments in recent years. Somatic genetic testing, which assesses for gene amplification and acquired mutations in tumor tissue, enables the identification of actionable mutations (i.e., biomarkers) to determine patients who may benefit from targeted therapies. Despite the progress made in somatic genetic testing, broad...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Genetic Testing
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasms

Share to Precision Medicine

Source

Identifiers

PMID: 41592934
DOI: 10.1146/annurev-med-050124-082437

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Accessibility of Somatic Genetic Testing for Cancer Treatment Decisions.PMID 41592934Read ↗

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.Semantic proximity Read ↗

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.Semantic proximity Read ↗

Genomic testing in oncology to improve clinical outcomes while optimizing utilization: the evolution of diagnostic testing.Semantic proximity Read ↗

Disparities in Cancer Genetic Risk Assessment and TestingSemantic proximity Read ↗

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.Semantic proximity Read ↗

Management of Cancer Genetic Testing: A Brief Overview.Semantic proximity Read ↗

When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?Semantic proximity Read ↗

Pivotal Role of Genetic Counselors in the Uptake of Germline Genetic Testing in Non-Metastatic Breast Cancer and the Impact of Testing on Surgical Decision Making.Semantic proximity Read ↗

The Perils of Single-Site Genetic Testing for Hereditary Cancer Syndromes in the Era of Next-Generation Sequencing.Semantic proximity Read ↗

Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meetSemantic proximity Read ↗

Disparities in Hereditary Genetic Testing in Patients with Triple Negative Breast Cancer.Semantic proximity Read ↗

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.